Cancer Care Breakthrough: NHIA, Roche Slash Treatment Costs by 80% in New Deal

The National Health Insurance Authority (NHIA) in Osun State has emphasized that mandatory health insurance offers a practical solution to the rising cost of cancer care in Nigeria. This was highlighted during a sensitisation programme held at the Obafemi Awolowo University Teaching Hospital Complex (OAUTHC), Ile-Ife, as part of preparations for the rollout of the NHIA-Roche cost-sharing cancer care initiative.

According to insights gathered from the event, the initiative enables cancer patients enrolled under the NHIA to access treatment at significantly reduced costs. Under the programme, Roche covers 50 percent of the cost of cancer medications, while NHIA covers an additional 30 percent. Enrollees are responsible for only the remaining 20 percent.

The Osun State NHIA Coordinator, Olalekan Falode, while addressing attendees, noted that health insurance is now mandatory in Nigeria and urged citizens—particularly cancer patients—to enroll in the scheme in order to benefit from such life-saving partnerships. He explained that even individuals who are newly registered can begin accessing partial support from Roche immediately, with full cost-sharing benefits kicking in upon confirmation of enrollment status.

Falode stressed that the high cost of cancer treatment makes it nearly impossible for many Nigerians to pay out-of-pocket, regardless of their financial status. He maintained that the only sustainable approach to tackling cancer is through collaborative financial support mechanisms like the NHIA-Roche partnership.

In remarks delivered to journalists at the event, Olayode Babarinde, Policy Lead for Healthcare System Partnerships at Roche Nigeria, confirmed that the initiative is expanding to 17 additional treatment centres nationwide, with OAUTHC Ile-Ife among the newly listed facilities. He stated that patients will soon have access to a broader range of cancer medications at subsidized rates across the designated locations.

Professor John Okeniyi, Chief Medical Director of OAUTHC, described the programme as a successful model of public-private collaboration aimed at reducing the burden of cancer care. He affirmed that the partnership would improve follow-up care and treatment outcomes for cancer patients at the facility.

The NHIA and Roche initiative is expected to bring critical relief to thousands of Nigerians struggling with cancer treatment costs, reinforcing the federal government’s ongoing push toward universal health coverage through compulsory insurance enrollment.